| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/11/2002 | DE10046970A1 New human P2Y1li gene, useful for treatment and diagnosis of associated diseases, and related proteins, antibodies and modulators, encodes G protein-coupled receptor |
| 04/11/2002 | DE10046960A1 Verfahren zur Herstellung einer aktiven, heterodimeren AMW-RT in prokaryotischen Zellen A process for producing an active heterodimeric AMV RT in prokaryotic cells |
| 04/11/2002 | DE10046625A1 Neue für das ndkA-Gen kodierende Nukleotidsequenzen New coding for the ndkA gene nucleotide sequences |
| 04/11/2002 | DE10045579A1 Neue für das atr61-Gen kodierende Nukleotidsequenzen New coding for the atr61 gene nucleotide sequences |
| 04/11/2002 | DE10043481A1 Humaner Antikörper gegen Endoglin (CD105) und seine Verwendung Human antibodies against endoglin (CD105) and its use |
| 04/11/2002 | CA2802193A1 A kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425169A1 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | CA2425152A1 Highly expressible genes |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
| 04/11/2002 | CA2425100A1 Method for generating cloned animals using chromosome shuffling |
| 04/11/2002 | CA2425092A1 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 04/11/2002 | CA2425076A1 Cloning endangered and extinct species |
| 04/11/2002 | CA2425072A1 Wt1 fusion polypeptides and methods for wt1 immunotherapy |
| 04/11/2002 | CA2424974A1 A nitrate-responsive plant root specific transcriptional factor |
| 04/11/2002 | CA2424953A1 Novel human proteases and polynucleotides encoding the same |
| 04/11/2002 | CA2424952A1 Listeria inocua, genome and applications |
| 04/11/2002 | CA2424890A1 Ethanol production in gram-positive bacteria with a stabilized mutation in lactate dehydrogenase |
| 04/11/2002 | CA2424834A1 Nogo receptor homologs |
| 04/11/2002 | CA2424749A1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 04/11/2002 | CA2424738A1 Retroviral vectors containing internal ribosomal entry sites |
| 04/11/2002 | CA2424730A1 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 04/11/2002 | CA2424722A1 Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips |
| 04/11/2002 | CA2424693A1 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
| 04/11/2002 | CA2424668A1 Targeting molecules for adenoviral vectors |
| 04/11/2002 | CA2424604A1 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | CA2424584A1 Detection of ras mutations |
| 04/11/2002 | CA2424567A1 Method to alter sugar moieties |
| 04/11/2002 | CA2424543A1 Component for vaccine |
| 04/11/2002 | CA2424296A1 Human anti-cd40 antibodies |
| 04/11/2002 | CA2424275A1 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/11/2002 | CA2424216A1 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | CA2424207A1 Stem cell differentiation-inducing promoter |
| 04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | CA2424178A1 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| 04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
| 04/11/2002 | CA2423729A1 Methods and probes for detection and/or quantification of nucleic acid sequences |
| 04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | CA2423656A1 Methods and compositions for enhancing angiogenesis |
| 04/11/2002 | CA2423462A1 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | CA2423307A1 Stabilisation of plasmid inheritance in bacteria |
| 04/11/2002 | CA2422642A1 Human prostate specific g-protein receptor hpraj70 |
| 04/11/2002 | CA2421960A1 Heavy chain libraries |
| 04/11/2002 | CA2421306A1 Virus-based amplification vector for plants |
| 04/11/2002 | CA2359648A1 Process for the production of amino acids |
| 04/10/2002 | EP1195442A2 Ribozyme amplified diagnostics |
| 04/10/2002 | EP1195440A1 Gene delivery vectors for stem cells |
| 04/10/2002 | EP1195439A2 Retroviral vector with heterologous sequences between the retroviral primer binding site and the retroviral splice donor site |
| 04/10/2002 | EP1195438A1 Genetic immunisation against cervical carcinoma |
| 04/10/2002 | EP1195437A1 Process for the recombinant production of proteins using a Plac/Np hybrid promoter |
| 04/10/2002 | EP1195436A1 Expression vectors with modified ColE1 origin of replication for control of plasmid copy number |
| 04/10/2002 | EP1195435A1 Truncated phosphodiesterase-7 polypeptides |
| 04/10/2002 | EP1195434A1 METHOD FOR CONSTRUCTING FULL-LENGTH cDNA LIBRARIES |
| 04/10/2002 | EP1195433A2 Respiratory chain enzyme genes of coryneform bacteria |
| 04/10/2002 | EP1195431A1 Process for producing l-lysine |
| 04/10/2002 | EP1195384A1 Snake proteins having antithrombotic activity |
| 04/10/2002 | EP1195382A2 Testis-specific gene |
| 04/10/2002 | EP1195381A1 Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes |
| 04/10/2002 | EP1195161A2 Anti-IgE vaccines |
| 04/10/2002 | EP1194877A2 Method and system for displaying dendrograms |
| 04/10/2002 | EP1194781A1 Method for conducting chemiluminescent binding assay |
| 04/10/2002 | EP1194756A2 Methods for identifying modulators of n-type ion channel inactivation |
| 04/10/2002 | EP1194595A1 Polymorphisms in the human hmg-coa reductase gene |
| 04/10/2002 | EP1194593A2 Amplification of nucleic acids with electronic detection |
| 04/10/2002 | EP1194590A2 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype |
| 04/10/2002 | EP1194587A1 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 04/10/2002 | EP1194584A1 Method for producing oligopolysaccharides |
| 04/10/2002 | EP1194581A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 04/10/2002 | EP1194580A1 In vitro reconstitution of segmented negative-strand rna viruses |
| 04/10/2002 | EP1194579A1 High-efficiency agrobacterium mediated transformation of cotton using petiole explants |
| 04/10/2002 | EP1194578A2 Enhanced expression of proteins using gfp |
| 04/10/2002 | EP1194577A1 Identification and overexpression of a dna sequence coding for 2-methyl-6-phytylhydroquinone-methyltransferase in plants |
| 04/10/2002 | EP1194576A1 Delivery system |
| 04/10/2002 | EP1194575A1 Modified human granulocyte-colony stimulating factor and process for producing same |
| 04/10/2002 | EP1194574A1 High efficiency transfection based on low electric field strength, long pulse length |
| 04/10/2002 | EP1194573A2 Arrays of catalytic or pre-catalytic nucleic acids |
| 04/10/2002 | EP1194572A2 Promoter sequences derived from fusarium venenatum and uses thereof |
| 04/10/2002 | EP1194571A1 Prostase vaccine |
| 04/10/2002 | EP1194570A1 Fusion proteins incorporating lysozyme |
| 04/10/2002 | EP1194569A2 Seripancrin |
| 04/10/2002 | EP1194568A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 04/10/2002 | EP1194567A1 Production of complex carbohydrates |
| 04/10/2002 | EP1194566A2 Gene therapy for enhancing and/or inducing angiogenesis |
| 04/10/2002 | EP1194565A1 Genes from corynebacterium glutamicum for the biosynthesis of folic acid and their use for the microbial production of folic acid |
| 04/10/2002 | EP1194563A1 Fimh adhesin-based vaccines |
| 04/10/2002 | EP1194562A1 The lactose operon of lactobacillus delbrueckii and its use for controlling gene transcription and/or expression in bacterial cells |
| 04/10/2002 | EP1194561A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 04/10/2002 | EP1194560A2 Antigenic neisserial peptides |
| 04/10/2002 | EP1194559A1 Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans |
| 04/10/2002 | EP1194558A2 Novel sgs3 plant gene and use thereof |
| 04/10/2002 | EP1194557A2 An interleukin-1 receptor antagonist and uses thereof |
| 04/10/2002 | EP1194556A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
| 04/10/2002 | EP1194555A1 Methods for making apo-2 ligand using divalent metal ions |
| 04/10/2002 | EP1194554A1 Delivery of trefoil peptides |
| 04/10/2002 | EP1194553A1 Polypeptides and polynucleotides related to a glycine transporter |
| 04/10/2002 | EP1194552A1 Nucleic acids coding for peptides having the biological activity of sorbin |
| 04/10/2002 | EP1194551A1 G-protein coupled receptor and dna sequences thereof |
| 04/10/2002 | EP1194550A1 Antimicrobial peptides derived from molluscs |
| 04/10/2002 | EP1194549A2 Human genes and gene expression products |
| 04/10/2002 | EP1194548A1 Novel pyrrhocoricin-derived peptides, and methods of use thereof |